Soleus Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-97,547
Closed -$9.95M 124
2023
Q2
$9.95M Sell
97,547
-77,045
-44% -$7.86M 1.11% 28
2023
Q1
$15.9M Buy
+174,592
New +$15.9M 1.64% 17